Recognition and management of children with nonalcoholic fatty liver disease

Research output: Contribution to journalArticle

Abstract

Objective: To review diagnostic challenges and management strategies in children with nonalcoholic fatty liver disease (NAFLD). Methods: Review of the literaure. Results: NAFLD is common in the United States and should be suspected in overweight or obese children with an elevated serum alanine aminotransferase level. The differential diagnosis for these patients is broad, however, and liver biopsy-the gold standard test-should be undertaken selectively after an appropriate workup. Patients should be counseled on lifestyle modifications, whereas Vitamin E therapy can be initiated for those with biopsy-proven disease. Conclusion: Providers should have a high degree of suspicion for NAFLD, approaching the workup and diagnosis in an incremental, step-wise fashion. Further research is needed to standardize the diagnostic approach, identify reliable, noninvasive diagnostic measures, and develop novel treatment modalities.

Original languageEnglish (US)
Pages (from-to)135-143
Number of pages9
JournalJournal of Clinical Outcomes Management
Volume23
Issue number3
StatePublished - Mar 1 2016

Fingerprint

Biopsy
Alanine Transaminase
Vitamin E
Life Style
Differential Diagnosis
Liver
Serum
Research
Non-alcoholic Fatty Liver Disease
Therapeutics
Distance Counseling

ASJC Scopus subject areas

  • Medicine(all)
  • Health Policy

Cite this

@article{6068d5184cd946f2a4b04bbbe1c2d428,
title = "Recognition and management of children with nonalcoholic fatty liver disease",
abstract = "Objective: To review diagnostic challenges and management strategies in children with nonalcoholic fatty liver disease (NAFLD). Methods: Review of the literaure. Results: NAFLD is common in the United States and should be suspected in overweight or obese children with an elevated serum alanine aminotransferase level. The differential diagnosis for these patients is broad, however, and liver biopsy-the gold standard test-should be undertaken selectively after an appropriate workup. Patients should be counseled on lifestyle modifications, whereas Vitamin E therapy can be initiated for those with biopsy-proven disease. Conclusion: Providers should have a high degree of suspicion for NAFLD, approaching the workup and diagnosis in an incremental, step-wise fashion. Further research is needed to standardize the diagnostic approach, identify reliable, noninvasive diagnostic measures, and develop novel treatment modalities.",
author = "Rudolph, {Bryan J.} and Debora Kogan-Liberman",
year = "2016",
month = "3",
day = "1",
language = "English (US)",
volume = "23",
pages = "135--143",
journal = "Journal of Clinical Outcomes Management",
issn = "1079-6533",
publisher = "Turner White Communications Inc.",
number = "3",

}

TY - JOUR

T1 - Recognition and management of children with nonalcoholic fatty liver disease

AU - Rudolph, Bryan J.

AU - Kogan-Liberman, Debora

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Objective: To review diagnostic challenges and management strategies in children with nonalcoholic fatty liver disease (NAFLD). Methods: Review of the literaure. Results: NAFLD is common in the United States and should be suspected in overweight or obese children with an elevated serum alanine aminotransferase level. The differential diagnosis for these patients is broad, however, and liver biopsy-the gold standard test-should be undertaken selectively after an appropriate workup. Patients should be counseled on lifestyle modifications, whereas Vitamin E therapy can be initiated for those with biopsy-proven disease. Conclusion: Providers should have a high degree of suspicion for NAFLD, approaching the workup and diagnosis in an incremental, step-wise fashion. Further research is needed to standardize the diagnostic approach, identify reliable, noninvasive diagnostic measures, and develop novel treatment modalities.

AB - Objective: To review diagnostic challenges and management strategies in children with nonalcoholic fatty liver disease (NAFLD). Methods: Review of the literaure. Results: NAFLD is common in the United States and should be suspected in overweight or obese children with an elevated serum alanine aminotransferase level. The differential diagnosis for these patients is broad, however, and liver biopsy-the gold standard test-should be undertaken selectively after an appropriate workup. Patients should be counseled on lifestyle modifications, whereas Vitamin E therapy can be initiated for those with biopsy-proven disease. Conclusion: Providers should have a high degree of suspicion for NAFLD, approaching the workup and diagnosis in an incremental, step-wise fashion. Further research is needed to standardize the diagnostic approach, identify reliable, noninvasive diagnostic measures, and develop novel treatment modalities.

UR - http://www.scopus.com/inward/record.url?scp=84961721993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961721993&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84961721993

VL - 23

SP - 135

EP - 143

JO - Journal of Clinical Outcomes Management

JF - Journal of Clinical Outcomes Management

SN - 1079-6533

IS - 3

ER -